Scarica l'app Stockscreener
0.7803
1.59%
0.0122
Precedente Chiudi:
$0.7681
Aprire:
$0.76
Volume 24 ore:
16,276
Relative Volume:
0.12
Capitalizzazione di mercato:
$22.59M
Reddito:
$26.55M
Utile/perdita netta:
$-91.72M
Rapporto P/E:
-0.2177
EPS:
-3.584
Flusso di cassa netto:
$-13.25M
1 W Prestazione:
+5.39%
1M Prestazione:
-2.03%
6M Prestazione:
-40.44%
1 anno Prestazione:
-64.53%
Intervallo 1D:
$0.75
$0.8436
Intervallo di 1 settimana:
$0.74
$0.8436
Portata 52W:
$0.5601
$4.35
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Compare CELU vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
0.7803 | 22.23M | 26.55M | -91.72M | -13.25M | -3.584 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
Press Release: Celularity Appoints Rick Gonzalez as Chief Commercial Officer - Moomoo
Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView
CELU Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView
Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com
Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com
Celularity Company Profile & Introduction - Moomoo
Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart
CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo
Celularity director Vincent LeVien resigns from board - TradingView
Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan
Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine
Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView
Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to earnings forward of Celularity Inc. – NASDAQ:CELU - TradingView
Celularity Appoints Chief Operating Officer - Moomoo
Celularity Strengthens Leadership With New Executive Appointments - The Globe and Mail
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary - TradingView
New leadership at Celularity (NASDAQ: CELU) as Gordon joins board - Stock Titan
Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU) - TradingView
Celularity Inc. (CELU) Q4 2025 Earnings: Narrowed Loss Beats Estimates, but Revenue Remains AbsentDiluted EPS Report - DonanımHaber
Form 4 Celularity Inc For: 23 June By Investing.com - Investing.com South Africa
Barach Family Trust (CELU) lets $2M note, warrant options lapse while holding large derivatives - Stock Titan
Celularity (NASDAQ: CELU) insider trust sees $2M note option expire - Stock Titan
Celularity (NASDAQ: CELU) major holder’s $2M note option and 839K warrants expire - Stock Titan
Form 13D/A Celularity Inc. For: 23 June By Investing.com - Investing.com Australia
Barach Family Trust updates 15.8% Celularity (CELU) stake in 13D/A - Stock Titan
CELU Technical Analysis & Stock Price Forecast - Intellectia AI
Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks
Celularity Inc (CELU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELUW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELUW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELUW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELUW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELUW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELUW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Institutional Confidence - TradingKey
Celularity Inc (CELUW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELU) Institutional Confidence - TradingKey
Celularity Inc. Warrant (CELUW) Holds at $0.01 Amid Minimal Volatility – Key Levels in FocusPCR Moving Average - newsline.com
Celularity Faces Nasdaq Listing Compliance Risk After Notice - The Globe and Mail
Celularity Inc. 8-K Filing June 2026: Nasdaq Listing, Company Details, and Securities Information - Minichart
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Celularity Inc Azioni (CELU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Haines John R | Senior Exec Vice President |
Apr 13 '26 |
Option Exercise |
0.00 |
1,641 |
0 |
30,762 |
| Hariri Robert J | Chief Executive Officer |
Apr 13 '26 |
Option Exercise |
0.00 |
3,281 |
0 |
2,854,735 |
0.80%
2.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):